Kopra Bio
YC S24San Francisco, US · Founded 2024 · 2 employees · 2 known investors
Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.
BiotechHealthtechMedical DevicesGene TherapySynthetic BiologyTherapeuticsOncologyin /kopra-bio@AF_Haddad
Founders & leadership· Y Combinator alumni (S24)
Alexander Haddadin𝕏Founder
Investors · 2
In the news
- UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancerendpoints.news · 2026
- Kopra Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2025
- Kopra Bio - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2025